Navigation Links
Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
Date:3/26/2013

ROCKVILLE, Maryland, March 26, 2013 /PRNewswire/ --

Biologists working in life sciences and pharmaceutical research now have access via the Web to molecular data from Elsevier and from articles obtained from other leading publishers

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of a web-based version of Pathway Studio, a research solution for biologists. Additionally, Pathway Studio now incorporates biological data from Elsevier's biology journals in addition to journals obtained through collaboration with third-party publishers. The addition of this data to Pathway Studio results in a resource that is unparalleled in depth and coverage of molecular interactions with supporting evidence. The new web-based version broadly extends access to researchers to reveal new insights and to assist with critical decision making.

"Currently, molecular facts are scattered in individual articles and researchers must gather and integrate these to advance new discovery," said Jaqui Mason , Product Development Director for Biology Products at Elsevier. "Pathway Studio presents these facts in a graphical context to help researchers assemble biological models that can be applied to target discovery programs, identify potential diagnostics, and reposition drugs. The new content included in Pathway Studio can expose a more complete picture in biology, which reduces risk, increases efficiency, and ultimately improves success rate whether it's bringing a new drug to market or exploring a theory."

"Incorporation of facts from Elsevier's biology journals into Pathway Studio, as well as building a pipeline of fresh data through our collaboration with third-party publishers, enables us to deliver additional value to our portfolio of solutions across biology, chemistry, and medicine in order to better serve the needs of customers in early discovery and biology researchers," said Mark van Mierle , Managing Director of Elsevier's Pharma and Biotech Group. "Offering a web-based version of Pathway Studio has allowed us to streamline common tasks and make the benefit of this content accessible to a broader and more general user-base."

The new web-based Pathway Studio adds additional early discovery capability to Elsevier's suite of life science information solutions which include Reaxys, the leading chemistry discovery engine, PharmaPendium which supports regulatory and safety activities, TargetInsights, a biological literature search system for early discovery and Quosa, which automates literature management workflows with applications in pharmacovigilance and medical affairs. This suite effectively delivers complementary solutions spanning early discovery, pre-clinical, clinical and post-launch workflows.

For more information, visit the new Pathway Studio website.

# # #

About Pathway Studio

Pathway Studio is integrated data mining and visualization software with high-quality, comprehensive knowledge bases produced by applying MedScan, Elsevier's proprietary text-mining technology, to a large corpus of biological literature. Pathway Studio allows organizations and researchers to rapidly connect relevant biological facts and relationships, visualize these facts in context, and integrate and interpret experimental data. Pathway Studio is used for defining and testing in silico-based hypotheses across a wide range of disciplines including mechanistic modeling of disease, drug action and toxicity, target discovery and validation, biomarker discovery, cellular and network pathway building, protein-protein interactions and many more.

Pathway Studio is offered in configurations that scale to support individual researchers and global corporations with access to domain specific knowledge bases and cartridges. For more information, visit the Pathway Studio website

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Liz Griffioen
Elsevier
+31-20-485-2247
l.griffioen@elsevier.com



'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
2. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
3. Elsevier Announces the Launch of a New Journal: Wound Medicine
4. Dr. Ali S. Faqi and Leading Scientists Author Ground-Breaking Toxicology Book from Elsevier
5. Elsevier and the Emergency Nurses Association Launch New eLearning Course Focused on Psychiatric Emergencies
6. Elsevier Aligns Solutions to Empower Meaningful Care
7. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
8. Elsevier Announces the Launch of a New Journal: Methods in Oceanography
9. Elsevier Launches Evidence-Based, Collaborative Order Sets Solution
10. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
11. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... October 09, 2019 , ... As ... County middle school and high school students have improved neuro-cognitive executive skills to ... and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, due ...
(Date:10/8/2019)... ... ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces the recent ... patent, approved in the U.S. in 2017, the new patent covers the company’s unique ... the technology in the U.S. as the AlphaSTEM Test™. The new patent will ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D imaging and ... run by the East Midlands Academic Health Science Network (EMAHSN), the innovation arm of ... NHS by providing support to develop and deploy solutions to the most pressing challenges ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as ... Organization, with MRSA becoming one of the most serious concerns. Hong Kong cannot be ... of community-associated MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the ...
Breaking Biology Technology:
(Date:10/15/2019)... , ... October 14, 2019 , ... ... laser therapy technology, today announces its upcoming Business Meeting in Orlando & 18th ... the Ritz Carlton in Orlando, near Erchonia’s headquarters in Melbourne. , The first ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a global developer ... the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit #841 and ... Orlando, Florida, and will provide more than 14,000 healthcare professionals from around the ...
(Date:10/8/2019)... Calif. (PRWEB) , ... October 07, 2019 , ... The ... down to the genetic level, resulting in people living longer, healthier lives. But it ... time on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder ...
Breaking Biology News(10 mins):